Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation

Alzheimer's and Dementia

Volumn 11, Issue 2, 2015, Pages 184-194

  Boccardi, Marina ^a   Bocchetta, Martina ^a   Ganzola, Rossana ^a   Robitaille, Nicolas ^b   Redolfi, Alberto ^a   Duchesne, Simon ^b   Jack, Clifford R ^c   Frisoni, Giovanni B ^a,d   Bartzokis, George ^e   Csernansky, John G ^f   De Leon, Mony J ^g   Detoledo Morrell, Leyla ^h   Killiany, Ronald J ⁱ   Lehericy, Stephane ^j   Malykhin, Nikolai ^k   Pantel, Johannes ^l   Pruessner, Jens C ^m   Soininen, Hilkka ⁿ   Watson, Craig ^o  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h RUSH MEDICAL COLLEGE   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j SORBONNE UNIVERSITÉ   (France)

^k UNIVERSITY OF ALBERTA   (Canada)

^l GOETHE UNIVERSITY   (Germany)

^m MCGILL UNIVERSITY   (Canada)

ⁿ KUOPIO UNIVERSITY HOSPITAL   (Finland)

^o DETROIT RECEIVING HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ALVEUS; ALZHEIMER DISEASE; ANATOMIC LANDMARK; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL FIMBRIA; HIPPOCAMPUS; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VOLUMETRY; AGED; ANATOMY AND HISTOLOGY; ATROPHY; DELPHI STUDY; DEVICES; IMAGE PROCESSING; NEUROIMAGING; ORGAN SIZE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; ATROPHY; DELPHI TECHNIQUE; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; ORGAN SIZE; REPRODUCIBILITY OF RESULTS;

EID: 84933501125     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.03.001     Document Type: Article

References (46)

1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-9.
2. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734-46.
3. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-92.
4. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-9.
5. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger- Gateau P, et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 2010;9:1118-27.
6. Collins DL, Pruessner JC. Towards accurate, automatic segmentation of the hippocampus and amygdala from MRI by augmenting ANIMAL with a template library and label fusion. Neuroimage 2010; 52:1355-66.
7. Rodionov R, Chupin M, Williams E, Hammers A, Kesavadas C, Lemieux L. Evaluation of atlas-based segmentation of hippocampi in healthy humans. Magn Reson Imaging 2009;27:1104-9.
8. Kennedy KM, Erickson KI, Rodrigue KM, Voss MW, Colcombe SJ, Kramer AF, et al. Age-related differences in regional brain volumes: A comparison of optimized voxel-based morphometry to manual volumetry. Neurobiol Aging 2009;30:1657-76.
9. Hasan KM, Pedraza O. Improving the reliability of manual and automated methods for hippocampal and amygdala volume measurements. Neuroimage 2009;48:497-8.
10. Bosscher L, Scheltens P. Functional imaging in dementia. In: Qizilbash N, ed. Evidence-based dementia practice. Oxford, UK: Blackwell; 2002. p. 162-9.
11. Duchesne S, Pruessner J, Collins DL. Appearance-based segmentation of medial temporal lobe structures. Neuroimage 2002;17:515-31.
12. Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, et al. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage 2008; 40:1655-71.
13. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, et al. Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease, mild cognitive impairment, and elderly control subjects. Neuroimage 2008;43:59-68.
14. Brewer JB, Magda S, Airriess C, Smith ME. Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 2009; 30:578-80.
15. Colliot O, Chetelat G, Chupin M, Desgranges B, Magnin B, Benali H, et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 2008;248:194-201.
16. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147-59.
17. Konrad C, Ukas T, Nebel C, Arolt V, Toga AW, Narr KL. Defining the human hippocampus in cerebral magnetic resonance images: An overview of current segmentation protocols. Neuroimage 2009; 47:1185-95.
18. Jack CR Jr, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 2011; 7:474-85.
19. Frisoni GB, Jack CR. Harmonization of magnetic resonance-based manual hippocampal segmentation: A mandatory step for wide clinical use. Alzheimers Dement 2011;7:171-4.
20. A Harmonized Protocol For Hippocampal Volumetry: An EADCADNI Effort. Available at: http://www.hippocampal-protocol.net/SOPs/index.html. Accessed April 9, 2013.
21. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, et al. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimer Dis 2011;26(Suppl 3)61-75.
22. A Harmonized Protocol For Hippocampal Volumetry: An EADC-ADNI Effort. Surveyed Protocols. Available at: http://www.hippocampal-protocol.net/SOPs/investigatedprotocols.html. Accessed April 9, 2013.
23. Murphy M, Black N, Lamping D, McKee C, Sanderson C, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998;2:1-88.
24. A Harmonized Protocol For Hippocampal Volumetry: An EADCADNI Effort. Flow Chart Validation. Available at http://www.hippocampal-protocol.net/SOPs/LINK-PAGE/Flow-chart-validation-phase.pdf Accessed April 9, 2013.
25. Alzheimer's Disease Neuroimaging Initiative. Available at: http://www.adni-info.org Accessed April 9, 2013.
26. Alzheimer's Disease Neuroimaging Initiative. Sharing Alzheimer's Research Data with the World. Available at: http://adni.loni.ucla.edu Accessed April 9, 2013.
27. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55:967-72.
28. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, et al. Simultaneous measurement of beta-amyloid(1- 42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 2005;51:336-45.
29. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects. Ann Neurol 2009;65:403-13.
30. Alzheimer's Disease Neuroimaging Initiative (ADNI). Data and Samples. Available at: http://adni.loni.usc.edu/data-samples. Accessed March 3, 2014.
31. Galluzzi S, Testa C, Boccardi M, Bresciani L, Benussi L, Ghidoni R, et al. The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions. Aging Clin Exp Res 2009;21:266-76.
32. Pruessner JC, Li LM, Serles W, Pruessner M, Collins DL, Kabani N, et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 2000;10:433-42.
33. Marker J, Braude I, Museth K, Breen D. Contour-based surface reconstruction using implicit curve fitting, and distance field filtering and interpolation. Proc Int Workshop Volume Graphics 2006;95-102.
34. Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997;18:131-8.
35. Bartzokis G, Altshuler LL, Greider T, Curran J, Keen B, Dixon WJ. Reliability of medial temporal lobe volume measurements using reformatted 3D images. Psychiatry Res 1998;82:11-24.
36. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993; 50:949-54.
37. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994; 15:929-37.
38. Malykhin NV, Bouchard TP, Ogilvie CJ, Coupland NJ, Seres P, Camicioli R. Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Res 2007;155:155-65.
39. Watson C, Jack CR Jr, Cendes F. Volumetric magnetic resonance imaging: clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol 1997;54:1521-31.
40. Haller JW, Banerjee A, Christensen GE, Gado M, Joshi S, Miller MI, et al. Three-dimensional hippocampal MR morphometry with highdimensional transformation of a neuroanatomic atlas. Radiology 1997;202:504-10.
41. Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35:S21-9.
42. deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004;25:1197-203.
43. Pantel J, O'Leary DS, Cretsinger K, Bockholt HJ, Keefe H, Magnotta VA, et al. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus 2000;10:752-8.
44. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hanninen T, Hallikainen M, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-8.
45. Mai JK, Assheuer J, Paxinos G. Atlas of the human brain. San Diego, CA: Academic Press; 1997.
46. Duvernoy HM. The human hippocampus: functional anatomy, vascularization and serial sections with MRI. 3rd ed. Berlin: Springer; 1998.